Takara Bio Europe today announced that it has joined forces with leading qPCR training provider TATAA Biocenter to offer free educational webinars in real-time PCR (qPCR) for academic and industrial researchers and laboratory technicians.
21 February, 2012
Xceleron, a leader in accelerating drug development using ultra-sensitive bioanalytical analyses, announced that existing investors Albion Ventures and Solon Ventures have invested US$2.4MM to locate all of the company’s business in its custom-built facility in Germantown, MD which is expected to be fully operational by 31st March 2012.
16 February, 2012
GlaxoSmithKline Pty Ltd (GSK) announced that it will invest $60 million to expand its manufacturing and new drug development activities in Victoria, Australia. The investment by one of the world’s leading pharmaceutical companies will create 58 new highly-skilled jobs by 2017.
08 February, 2012